Teva Pharmaceutical Industries Limited (TEV) — Cash Flow Quality Index
Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow Quality Index of -0.11x as of March 2026. Operating cash flow of €-40.00 Million is below net income of €369.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Teva Pharmaceutical Industries Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Teva Pharmaceutical Industries Limited Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Teva Pharmaceutical Industries Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Teva Pharmaceutical Industries Limited (TEV) cash conversion ratio.
Annual Cash Flow Quality Index for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year earnings quality comparison for Teva Pharmaceutical Industries Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | €1.65 Billion | €1.41 Billion | ▼ -38.9% |
| 2021 | 1.91x | €798.00 Million | €417.00 Million | ▼ -83.8% |
| 2016 | 11.82x | €3.89 Billion | €329.00 Million | ▲ +238.8% |
| 2015 | 3.49x | €5.54 Billion | €1.59 Billion | — |